The Pharmacy Times® Weight Management Resource Center is a comprehensive resource for clinical news and expert insights on issues related to chronic obesity and the associated health issues.
April 18th 2025
The findings suggest a potentially elevated risk of vision impairment with semaglutide (Ozempic, Wegovy; Novo Nordisk) use compared to other weight loss and diabetes medications.